Latest California Healthline Stories
A Guide to Long-Term Care Insurance
Deciding when, or whether, to buy long-term care insurance can be complex. Here’s what to know.
From Hospital to Hospitality: Spin Doctors Brand Getting Sick as an Adventure. It’s Not.
At $1,000 a night for a private room, medical centers are offering fancy food and casting health care as a “journey.” Instead of creature comforts, how about helping us feel better?
Out for Blood: For Routine Lab Work, the Hospital Billed Her $2,400
Convenient as it may be, beware of getting your blood drawn at a hospital. The cost could be much higher than at an independent lab, and your insurance might not cover it all.
Extra Fees Drive Assisted Living Profits
The add-ons pile up: $93 for medications, $50 for cable TV. Prices soar as the industry leaves no service unbilled, out of reach for many families.
What to Know About Assisted Living
The facilities can look like luxury apartments or modest group homes and can vary in pricing structures. Here’s a guide.
New Social Security Report Shows Growing Overpayment Problem Tops $23B
Social Security has been overpaying recipients for years, then demanding the money back, leaving people with bills for up to tens of thousands of dollars or more.
Beyond Insulin: Medi-Cal Expands Patient Access to Diabetes Supplies
California’s Medicaid program is making it easier for people with diabetes to obtain the supplies and equipment they need to manage their blood sugar, partly by relaxing preauthorization requirements that can cause life-threatening delays.
Facing Financial Ruin as Costs Soar for Elder Care
The United States has no coherent system of long-term care, leading many to struggle to stay independent or rely on a patchwork of solutions.
What Long-Term Care Looks Like Around the World
Most countries spend more than the United States on care, but middle-class and affluent people still bear a substantial portion of the costs.
A New RSV Shot Could Help Protect Babies This Winter — If They Can Get It in Time
Supply problems, a high price tag, and bureaucratic obstacles are slowing the distribution of a therapy that can protect infants from the respiratory syncytial virus. That will leave them unnecessarily at risk of hospitalization this winter, pediatricians fear.